The intraperitoneal injection (IP) of HSV-HF10 in a murine ovarian cancer murine model, together with the anti-tumour effect of GM-CSF, led to a reduction in tumour size and an increase in anti-tumour immune response [41]. The gene discussed is CSF2; the disease is neoplasm.